Yes my thoughts exactly. 85% hit rate without the virus reservoir known.
There will be other methods found to detect XMRV in humans, (e.g. CSF fluid) which also would up the abilty to detect XMRV.
Looks like we will soon have an FDA approved diagnostic test for patients (via the WPI) with XMRV induced neuro immune disease at last, who were told they have CFS.
If FDA could do this via october, then the FDA would have effectively (by proxy) 'made' an approved XMRV test within 12 months of the SCIENCE paper.
As we have been kindly informed look for changes to the VIPDX website very soon with upgraded XMRV tests, whose new home will become the WPI.
Hopefully, this all links in with the FDA paper.
VIP Dx has also recently entered into an agreement to be acquired by the Whittemore Peterson Institute, and become an integral part of the Institute. The clinical laboratory will continue to operate under the name VIP Dx, until it moves to the University of Nevada's Center for Molecular Medicine in August 2010. At that time, the lab will operate within the Institute under the name Unevx, providing services and revenue to the Institute in a manner similar to other institutional clinical reference laboratories.